Executive manager of the 'COV-Iran Barkat' vaccine's clinical trial says the COV-Iran Barakat vaccine's efficiency is the same as imported vaccines, and it has no side effects and its immunogenicity is 80 present.
If you want to know more, please click here
If you want to have Iran Press News Agency video without logo, please click here